Dr. Roberto J Sartori, M.D. Psychiatry & Neurology - Sleep Medicine Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Brooke Army Medical Center, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-0901 Fax: 210-916-2100 |
Dr. Johanna Marie Brueckner, D.O. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-808-2584 |
Dr. David Matthew Keller, M.S., D.O. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3551 Roger Brooke Dr, Quality Services/ Attn: Mche-zqq, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-2338 |
Dr. Yenwen Chao, DO Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-2203 |
Tyler Koehn, MD Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-539-9582 |
Dr. Thomas Michael Duginski, M.D. Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-2203 Fax: 210-916-3833 |
Dr. Timothy Richard Fullam, M.D. Psychiatry & Neurology - Neuromuscular Medicine Medicare: Medicare Enrolled Practice Location: 3551 Roger Brooke Dr, Jbsa Ft Sam Houston, TX 78234 Phone: 210-916-2203 Fax: 210-916-2203 |
News Archive
When bedbound intensive care patients are moved within a hospital, the single most common risk factor is nonfunctioning technology and equipment. These transfers, a well-known moment of risk, have been studied in a University of Gothenburg thesis.
Over 200,000 smokers managed to kick the smoking habit last year in the best results ever achieved by the service - 65 per cent up on the previous year.
"When it comes to getting aid right, an all-too-familiar problem seems to be balancing the priorities of rich governments with what communities actually want," AlertNet reports in an article examining an essay written by Oxford University researcher Devi Sridhar and published in PLOS Medicine.
Morphotek Inc., a wholly-owned subsidiary of Eisai Inc., announced today top-line results from a Phase III study of its investigational agent farletuzumab (MORAb-003) in combination with carboplatin and a taxane in patients with platinum-sensitive epithelial ovarian cancer in first relapse.
Thalia Goldstein, Associate Professor of Applied Developmental Psychology, is studying lies parents tell their children.
› Verified 5 days ago